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Abstract: This study was designed to evaluate the in vitro chondrogenic differentiation potential of equine adipose tissue-derived
mesenchymal stem cells (AT-MSCs) in response to different culture conditions. Fat tissue cells after collection were cultured in
optimized conditions until passage 3 (P3). P3 cells were cultured as micropellets under different chondrogenic conditions for 21 days
in 5 groups: basic medium as a control, basic chondrogenic medium (BCM), BCM supplemented with transforming growth factor beta
3 (TGF-β3; 10 ng/mL), BCM supplemented with bone morphogenetic protein 6 (BMP-6; 10 ng/mL), and BCM supplemented with
both TGF-β3 and BMP-6. The growth rate of pellets was measured and differentiation progression was assessed by specific stainings
and gene expression profiling. Results showed that the largest pellets of cells belonged to the group containing both growth factors. All
treated cells showed different levels of chondrogenic differentiation compared to the control group (P < 0.05). The differentiation score
in groups containing TGF-β3 and both growth factors was significantly greater than that in other groups. Moreover, the expression of
aggrecan, as a cartilage-specific gene, was confirmed in all groups expect the control group. Taken together, these results indicate that
the addition of both TGF-β3 and BMP-6 to BCM potentiates the chondrogenic differentiation of equine AT-MSCs.
Key words: Mesenchymal stem cells, equine, chondrogenic differentiation, TGF-β3, BMP-6

1. Introduction
In recent decades, the isolation of different types of stem
cells and their use in human and veterinary regenerative
medicine has been highly regarded. Recent advances
in stem cell research have provided new hopes for the
treatment of diseases and disorders that have not so far
been remediable. Thus, the isolation of various types of
stem cells, including embryonic and adult, has attracted
the attention of many researchers. Repair and regeneration
of articular cartilage provides a substantial challenge
in regenerative medicine, due to the high degree of
morphologic and mechanical complexity intrinsic to the
hyaline cartilage (Somoza et al., 2014).
Adipose tissue of adult animals is a potential source
of mesenchymal stem cells (MSCs) for tissue engineering
and regenerative medicine, which could be used in the
treatment of musculoskeletal diseases in veterinary
medicine (Baksh et al., 2004). Adipose tissue can be easily
collected from different parts of the body (Vater et al.,
2011) and the differentiation potential of equine MSCs
derived from adipose tissue is almost the same as that of
* Correspondence: parham@um.ac.ir
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MSCs derived from bone marrow (Ribitsch et al., 2010).
Adipose tissue-derived MSCs (AT-MSCs) are capable
of differentiating into multiple cell lines including bone,
cartilage, tendon, and ligament in both in vitro and in vivo
models (Zuk et al., 2001; Park et al., 2010). The in vitro
differentiation of equine MSCs into the cartilage upon
different treatments ( Fortier et al., 1998; Worster et al.,
2001; Hegewald et al., 2004; Arnhold et al., 2007; Stewart
et al., 2007; Vidal et al., 2007; Giovannini et al., 2008) is
being actively pursued. Thus, defining a more suitable
condition for chondrogenic differentiation of equine ATMSCs is necessary.
Ligands of Notch and families of growth factors like
transforming growth factor-beta (TGF-β), insulin-like
growth factors (IGFs), and fibroblast growth factors
(FGFs) play important roles for the formation of cartilage
(Pogue and Lyons, 2006). Bone morphogenic proteins
(BMPs) are members of the TGF superfamily that regulate
cartilage and bone formation. The BMP-6 and TGF-β3
combination also has an anabolic effect on MSC pellet
size (Vidal et al., 2008). TGF-β induces the expression of
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chondrogenic markers such as BMP-6 that are involved in
increasing the size and weight of the cultured pellets and
producing matrix proteoglycans (Worster et al., 2000).
Due to the expression of many typical biomolecules of
hyaline cartilage, such as collagen type II and aggrecan, the
resulting differentiated tissue can be classified as cartilage
(Somoza et al., 2014). Therefore, the main objective of this
study was to evaluate the effect of BMP-6 and TGF-β3 on
the in vitro chondrogenic differentiation of equine stem
cells isolated from adipose tissue.
2. Materials and methods
The experimental protocols were approved by the
Committee of Ethics and Animal Welfare of the School
of Veterinary Medicine, Ferdowsi University of Mashhad,
and were performed according to international guidelines
for the care and use of experimental animals. In this study,
3 healthy crossbred mares were used for collection of
adipose samples. All chemical reagents were obtained from
Sigma-Aldrich (St. Louis, MO, USA) unless otherwise
noted.
2.1. Fat tissue sampling
Adipose tissue was collected from the region above the
dorsal gluteal muscles. The horses were sedated with
xylazine (0.7 mg/kg, i.v.) followed by subcutaneous
injection of 2% lidocaine chloride with epinephrine using
an inverted L-block. An incision of approximately 5 cm
in length was performed parallel to and approximately
10 cm below the spinal column. Approximately 2–3 g of
adipose tissue was collected and stored in a sterile 50-mL
tube containing phosphate-buffered saline (PBS) plus
penicillin-streptomycin.
2.2. Cell isolation, culture, and expansion
In order to eliminate possible contamination of blood
samples taken from fat, samples were minced with a
scalpel blade and washed in PBS solution containing
2% penicillin-streptomycin and 1% amphotericin B.
Enzymatic digestion was performed by collagenase type
I (0.1% plus 1% bovine serum albumin in PBS). Four
milliliters of prepared enzyme was added to the fat content.
The digestion container was incubated for 2 h at 37 °C and
5% CO2 and was shaken vigorously every 10 min. The
digested content was passed through a 70-µm cell strainer
into Falcon tubes. The enzyme activity was neutralized
by addition of Dulbecco’s modified Eagle’s medium
(DMEM) containing 10% fetal bovine serum (FBS) in
the ratio of 3 parts medium to 1 part digestion medium.
Samples were centrifuged at 600 × g for 5 min. After
centrifugation, three phases of supernatant (suspended
fat, adipose tissue, and PBS solution) were evacuated by
a pipette. To the remaining pellet, 2 mL of DMEM-high
glucose culture medium was added to resuspend and
count the cells. The isolated cells were cultured in 75-cm2

flasks with a concentration of 8 × 104 cells/cm2 in DMEM
containing 10% FBS, 100 µg/mL streptomycin, 100 IU/mL
penicillin, and 0.1% amphotericin B and incubated at 37
°C with 5% CO2 (passage zero). Every 3 days, the culture
medium was replaced with fresh medium and suspended
cells were removed from the flask. Cells at a confluency of
approximately 80% were passaged using trypsinization by
TrypLE solution (Invitrogen). Cell culture was continued
until passage 3 (P3).
2.3. Experimental design for chondrogenic differentiation
To perform chondrogenesis experiments, 5 × 105 cells of
P3 were transferred into a 15-mL Falcon tube to form a
micropellet culture system. Cells were centrifuged for 5
min at 260 × g to form pellets. After 24 h, the supernatant
was discarded and 2 mL of cartilage-inducing medium was
used for treatment groups. Every 3–4 days, culture medium
was replaced with fresh medium. Basic chondrogenic
medium (BCM) contained DMEM-high glucose with
10% FBS, 100 µg/mL streptomycin, 100 IU/mL penicillin
and 0.1% amphotericin B, 0.1 µM dexamethasone, 50 µM
2-phospho-L-ascorbic acid trisodium, 1% ITS (insulintransferrin-selenium), and 1 mg of bovine serum albumin.
This study was designed in 5 groups with 9 replicates in
each group: 1) control group: cells treated with basic
medium containing DMEM-high glucose with 10% FBS,
100 µg/mL streptomycin, 100 IU/mL penicillin, and 0.1%
amphotericin B; 2) cells treated with BCM without growth
factors; 3) cells treated with BCM supplemented with 10
ng/mL growth factor BMP-6; 4) cells treated with BCM
supplemented with 10 ng/mL growth factor TGF-β3;
and 5) cells treated with BCM supplemented with both
TGF-β3 and BMP-6 at a concentration of 10 ng/mL. Pellets
were treated for 21 days at 37 °C and 5% CO2. After this
period, histological evaluation by specific staining and the
expression of cartilage-specific genes were studied.
2.4. Size determination and histological analysis of
pellets
At the end of the differentiation period (day 21), the
circumferences of all pellets in different groups were
measured. Multiple sections of all pellets were prepared
and stained with toluidine blue to evaluate proteoglycans,
Alcian blue (pH 2.5) to evaluate glycosaminoglycan (GAG)
deposition, Masson’s trichrome to evaluate collagen
filament formation, and hematoxylin and eosin (H&E)
to evaluate the microscopic morphology of the pellet. To
evaluate progression toward chondrogenic differentiation,
all sections (5 replicates in each group) were examined
by 3 histologists (blind observers). Each group received
an overall score from 1 to 5 based on the stage of
differentiation (1 for lack of differentiation signs and 5 for
maximum differentiation). The means of the 3 histologists’
observations were calculated and were used for data
analysis. Progression of chondrogenic differentiation was

361

SHADEMAN et al. / Turk J Biol

scored based on some cartilage characteristics including
cell morphology, lacunae formation, distance between
cells, staining intensity of collagen, and proteoglycans and
glycosaminoglycan in matrix.
2.5. Gene expression analysis
RNA was extracted by the High Pure Kit (Roche, Germany).
DNase treatment was included in the isolation protocol.
The concentration and quality of RNA were evaluated with
a NanoDrop spectrophotometer (Thermo Scientific, USA)
and gel electrophoresis. One microgram of total RNA was
reverse-transcribed into cDNA using the AccuPower RT
Premix (Bioneer, South Korea) and 0.5 µg of oligothymidine
in the presence of 1 mM dNTPs mix at 42 °C.
Specific primers for PCR amplification of GAPDH
(housekeeping gene), aggrecan, and collagen type II were
designed (Table 1). One microliter of each RT reaction
was used as a template for PCR reactions (35 cycles) in a
final volume of 25 µL with 0.2 mM dNTP mix, 20 pmol of
each primer, 1.25 U SmarTaq DNA polymerase, 1.5 mM
MgCl2 and 5 µL 10X PCR buffer. Amplified cDNAs were
visualized by 1.5% agarose gel electrophoresis and staining
with ethidium bromide. The amplification of GAPDH was
used as a positive internal control for all samples to verify
that the reverse transcription-polymerase chain reactions
(RT-PCRs) were successful. Cartilage tissue was used as a
positive control.
2.6. Statistical analysis
Pellet size data are presented as mean ± SD and were
analyzed by analysis of variance (ANOVA) using SPSS
21.0 (IBM Corp., USA), and when ANOVA demonstrated
an overall significant effect, differences between means
were analyzed using the Bonferroni t-test. The mean data
regarding the scoring differentiation were evaluated by
Kruskal–Wallis test. P < 0.05 was considered significant.
3. Results
3.1. Cell isolation and expansion
In the first few days of culture, single cells with spindleshaped appearance (Figure 1a) attached to the bottom of
the culture flask and began to proliferate after a delay of

several days to form colonies around day 7 (Figure 1b). On
days 8 to 10, the cells proliferated as individual colonies
with a fibroblast-like morphology. The cells became
more elongated within 18 to 21 days of culture with 80%
confluency (Figure 1c). The cells at passage 0 were isolated
and subcultured until P3, resulting in a relatively uniform
population of fibroblast-like cells.
3.2. Confirmation of MSC characteristics
Minimal criteria (De Schauwer et al., 2011; Alipour et al.,
2014) for identification of isolated MSCs including sticking
to the bottom of the flask, expression of specific markers,
and differentiation to adipocytes and osteocytes were
evaluated. The isolated cells were plastic-adherent with a
fibroblast-like phenotype. The cells exhibited expression of
mesenchymal markers (CD29, CD44, and CD90) and not
MHC-II and CD34. Moreover, the potential of adipogenic
and osteogenic differentiation of cells was confirmed.
3.3. Comparison of pellet size in different treatment
groups
At the end of the differentiation period, data analysis of
pellet size showed that pellet circumference in all treatment
groups was larger than that in control group (P < 0.05).
Pellet circumference in groups containing growth factor(s)
was significantly larger than that in the chondrogenic
group without growth factor. Although the largest pellets
belonged to the group containing both growth factors,
there was no significant difference in pellet size among
groups containing either or a mix of the growth factors
(Figures 2 and 3).
3.4. Histological studies using different staining methods
Using specific staining methods, different signs of cartilage
differentiation were evaluated in studied samples (Figure
4). All treated cells showed different levels of chondrogenic
differentiation compared to the control group (P < 0.05).
Differentiation score in groups containing TGF-β3 and
both growth factors was significantly greater than that in
the chondrogenic group without growth factor and the
group with BMP-6. Differentiation score in the group
containing both growth factors was insignificantly (P >
0.05) greater than the group with only TGF-β3 (Table 2).

Table 1. Nucleotide sequences of the primer sets used for RT-PCR.
Genes

GenBank accession
number

Primer pairs

Annealing
temperature (°C)

Amplicon
size (bp)

Equine GAPDH

NM_001163856

F: TGTCATCAACGGAAAGGC
R: GCATCAGCAGAAGGAGCA

56

183

Equine Aggrecan

AF019756.1

F: CTACGACGCCATCTGCTACA
R: ACCGTCTGGATGGTGATGTC

52

110

Equine collagen, type II

NM_001081764

F: TACACTCAAGTCCCTCAACAAC
R: AGAGCGGAGACTACTGGATTG

52

130
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Figure 1. Morphological characteristics of isolated equine mesenchymal stem cells. A) The first single cells attached to the bottom
of the flask on day 4 of primary culture (100×). B) Colonies formed on day 7 of primary cell culture (40×). C) High cell density at
passage 0, on day 14 of primary cell culture (40×).

Figure 2. Pellet size of isolated equine mesenchymal stem cells cultured under different
conditions measured on day 21 of primary culture. Macroscopic (left) and microscopic
(right) photos show pellet sizes in different treatments. Pellets from left to right belong
to the control (C), chondrogenic (CH), CH + TGF-β3, CH + BMP-6, and CH + BMP-6 +
TGF-β3 groups. The pellet size in groups with growth factors is larger than in the control
and the group without growth factor.
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Figure 3. Pellet circumference measurements. Pellet size in all treated groups is larger
than in the control group (P < 0.05). Pellet circumference in groups containing growth
factor(s) was significantly larger than in the chondrogenic group without growth factor.
There was no statistically significant difference among groups containing growth factors
compared to each other. Data are represented as mean ± SD. Different letters (a, b, c)
show significant differences. CH: Chondrogenic.

Hematoxylin and eosin, toluidine blue, Alcian blue,
and Masson’s trichrome staining revealed that in groups
containing TGF-β3 and both factors, the histological
markers of cartilage tissue were present. In the groups
with growth factors, the stretched and star-shaped cells
had turned into spherical cells, lacunae had formed,
glycosaminoglycan and proteoglycans had been deposited,
and collagen filaments were present.
3.5. Expression of cartilage-specific genes
All treatment groups except the control group showed the
expression of aggrecan (in all 3 examined samples). The
collagen 2 transcript was not amplified in any of the five
groups, indicating that collagen had not been expressed in
detectable amounts (Figure 5).
4. Discussion
In veterinary science, stem cell therapy can be used to
treat incurable diseases such as articular cartilage and
tendon and ligament lesions of expensive racing horses
(Alves et al., 2011; Calloni et al., 2014). Regenerative
medicine and tissue engineering is focused on cell therapy
with growth factors to repair tissues such as tendons
and ligaments (Koch et al., 2007). The chondrogenic
potential of equine MSCs isolated from different sources
has been investigated and the prominent effect of cell
sources on chondrogenic differentiation potential has
been reported (Fortier et al., 1998; Arnhold et al., 2007;
Stewart et al., 2007; Giovannini et al., 2008; Vidal et al.,
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2008; Penny at el., 2012; Burk et al., 2013). Some studies
have determined the best chondrogenic differentiation for
bone marrow MSCs (Giovannini et al., 2008; Vidal et al.,
2008, Penny et al., 2012), whereas others have indicated
the prominent differentiation for cord blood MSCs and
the weakest differentiation for bone marrow MSCs (Burk
et al., 2013). These controversial findings show that the
source of MSCs and culture conditions are two main
issues in the therapeutic applications of MSCs. Due to the
easier accessibility and higher proliferation competency
of AT-MSCs than MSCs from other sources (Niyaz et al.,
2012; Penny et al., 2012), in this study, we tried to focus
on the isolation and characterization of equine MSCs from
adipose tissue and differentiate them to chondrocytes. In
addition, we compared different conditions to optimize
chondrogenic differentiation potential of equine AT-MSCs
and found that supplementation of chondrogenic medium
with BMP-6 or TGF-β3 and especially with both of them
enhanced the potential of these cells for chondrogenic
differentiation.
Enhancing the ability of AT-MSCs for chondrogenic
differentiation is an interesting subject, as these cells
are easily available and abundant in fat tissue. However,
their chondrogenic differentiation potential seems to
be less than that of MSCs derived from other sources
such as bone marrow (Dragoo et al., 2007; Vidal et al.,
2008) or cord blood (Burk et al., 2013).Vidal et al. (2007,
2008) isolated and characterized equine AT-MSCs and

Figure 4. Histological analysis of pellets by H&E, toluidine blue, Alcian blue, and Masson’s trichrome staining (100× magnification for the left column and 10×
magnification for the right column). Lacuna formation is seen with H&E staining in group CH + TGF-β3 and the group with both growth factors. Produced extracellular
matrix, proteoglycans, and aggrecan are visible in pellets treated with chondrogenic medium supplemented with growth factors. Intensity of color shows that the
formation of matrix and collagen in groups containing growth factors is more than that in groups without growth factors. CH: Chondrogenic.
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Table 2. Overall score for progression of chondrogenic differentiation
determined by histologic observations. Data are presented as medians.
Group

Overall score

Basic medium

1.41a

Basic chondrogenic medium (BCM)

2.50b

BCM + BMP-6

3.16b

BCM + TGF-β3

3.83c

BCM + BMP6 + TGF-β3

4.16c

Histologic sections were scored by 3 expert histologists regarding the
progression of chondrogenic differentiation and the means of the 3 histologists’
observations were used for data analysis. A score of 1 is considered for lack of
differentiation and 5 for maximum differentiation. Different letters (a, b) show
statistically significant differences.

Figure 5. Electrophoresis of the amplified products from cDNA using GAPDH, aggrecan, and collagen 2 primers. A) Expression
of all 3 genes is detected in the positive control (cartilage). B) Expression of GAPDH as a housekeeping gene is confirmed in
all samples. C) Expression of aggrecan in all groups. D) Expression of collagen type 2 was not detected in any group except the
positive control. Ctrl+: Positive control (cartilage); Ctrl: control group; Chondrogenic: group containing only basic chondrogenic
medium (BCM) without growth factors; TGF-β3: group containing BCM supplemented with TGF-β3; BMP-6: group containing
BCM supplemented with BMP-6 growth factor; TGF-β3 & BMP-6: group containing BCM supplemented with TGF-β3 and BMP-6
growth factors; NTC: nontemplate control; and RT-: reverse transcriptase minus.
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differentiated these cells into fat, bone, and cartilage.
Their results indicated that the presence of growth factors
improved the chondrogenic differentiation of equine ATMSCs (Vidal et al., 2008). It has also been suggested that
TGF-β and dexamethasone are essential but not sufficient
for the chondrogenic differentiation of human AT-MSCs.
It was also observed that in pellet culture conditions,
BMP-6 improves the differentiation of human MSCs into
cartilage (Sekiya et al., 2001). Our findings confirmed that
the presence of BMP-6 and TGF-β3 and especially their
combination potentiates chondrogenic differentiation of
equine AT-MSCs, in agreement with previous studies.
Different studies have used various regimens of growth
factors to evaluate the chondrogenic potential of MSCs and
especially AT-MSCs (Worster et al., 2000, 2001; Estes et
al., 2006; Stewart et al., 2007; Somoza et al., 2014). TGF-β
and BMPs are the best candidates to induce chondrogenic
phenotype (Tapp et al., 2009). BMP-6 induces the
expression of TGF-β1 receptor in micromass culture, and
BMP-6 with TGF-β increases the chondrogenic potential
of stem cells derived from adipose tissue (Hennig et al.,
2007). TGF-β3 increases the chondrogenic potential of
human bone marrow stem cells due to its putative role
in the regulation of cell adhesion molecules, cytokines,
and synthesis of cytokine receptors (Hennig et al., 2007).
TGF-β3 and BMP-6 in human AT-MSCs in alginate
culture control the induction of chondrogenesis and
increase the mRNA level of collagen type II (Estes et al.,
2006). Henning et al. (2007) acquired similar results for
human AT-MSCs and bone marrow MSCs by adding
BMP-6 to the culture medium. Cartilage differentiation
is accompanied by reducing the expression of collagen
type I and increasing the expression of collagen types II,
VI, and IX and aggrecan (Dragoo et al., 2007). Although
TGF-β can induce bone marrow MSCs, AT-MSCs require
both TGF-β and BMP-6 (Zhang et al., 2010). In our study,
the microscopic appearance of pellets that were grown on
medium containing both growth factors showed lacunae
and hyaline cartilage formation. This finding was in
contrast to the results acquired by Vidal et al. (2008), who

stated that the differentiated pellets had no evidence of
lacuna formation and hyaline cartilage. It has been proven
that other factors like oxygen tension and culture system
affect chondrogenic capability of MSCs. Co et al. (2014)
succeeded in increasing the hyaline cartilage production
from equine cord blood MSCs in membrane culture at 5%
oxygen condition.
In addition to specific staining, chondrogenic
differentiation can be confirmed by evaluation of
cartilage-specific gene expression. Aggrecan expression, as
a cartilage-specific gene, was confirmed in all pellets that
were grown on chondrogenic medium with or without
growth factors. This finding confirms the results of Dragoo
et al. (2007). Although aggrecan expression was detectable
in the BCM group and the group containing BMP-6,
the cells did not assume clear chondrocyte morphology
in these groups, which shows a limited progression of
chondrogenic differentiation. No expression of collagen
type II was observed in the treatment groups, while it was
present in the positive control (articular cartilage) group.
Since the presence of collagen filaments was confirmed
by specific staining, lack of amplification of collagen
transcript can be contributed to either very low levels of
collagen type II transcription in treated groups or likely
the transcription of other types of collagen such as types
VI and IX.
In conclusion, we found that the addition of BMP-6 and
TGF-β3 alone or together to the conventional chondrogenic
medium improves the chondrogenic potential of equine
AT-MSCs. Due to the availability and abundance of fat
tissue, optimization of the chondrogenic differentiation of
AT-MSCs makes them an attractive choice of cells for use
in regenerative medicine and tissue engineering.
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